» Articles » PMID: 22253721

Genome-wide High-resolution ACGH Analysis of Gestational Choriocarcinomas

Abstract

Eleven samples of DNA from choriocarcinomas were studied by high resolution CGH-array 244 K. They were studied after histopathological confirmation of the diagnosis, of the androgenic etiology and after a microsatellite marker analysis confirming the absence of contamination of tumor DNA from maternal DNA. Three cell lines, BeWo, JAR, JEG were also studied by this high resolution pangenomic technique. According to aCGH analysis, the de novo choriocarcinomas exhibited simple chromosomal rearrangements or normal profiles. The cell lines showed various and complex chromosomal aberrations. 23 Minimal Critical Regions were defined that allowed us to list the genes that were potentially implicated. Among them, unusually high numbers of microRNA clusters and imprinted genes were observed.

Citing Articles

Gestational trophoblastic disease: understanding the molecular mechanisms of placental tumours.

Nicheperovich A, Schuster-Bockler B, Ni Leathlobhair M Dis Model Mech. 2025; 18(1).

PMID: 39873178 PMC: 11810044. DOI: 10.1242/dmm.052010.


Sensitive screening of single nucleotide polymorphisms in cell free DNA for diagnosis of gestational tumours.

Maher G, Fisher R, Kaur B, Aguiar X, Aravind P, Cedeno N NPJ Genom Med. 2022; 7(1):26.

PMID: 35396509 PMC: 8993869. DOI: 10.1038/s41525-022-00297-x.


Inherent mosaicism and extensive mutation of human placentas.

Coorens T, Oliver T, Sanghvi R, Sovio U, Cook E, Vento-Tormo R Nature. 2021; 592(7852):80-85.

PMID: 33692543 PMC: 7611644. DOI: 10.1038/s41586-021-03345-1.


Epigenetic modifications at DMRs of placental genes are subjected to variations in normal gestation, pathological conditions and folate supplementation.

Rahat B, Mahajan A, Bagga R, Hamid A, Kaur J Sci Rep. 2017; 7:40774.

PMID: 28098215 PMC: 5241688. DOI: 10.1038/srep40774.


Oncogenomic portals for the visualization and analysis of genome-wide cancer data.

Klonowska K, Czubak K, Wojciechowska M, Handschuh L, Zmienko A, Figlerowicz M Oncotarget. 2015; 7(1):176-92.

PMID: 26484415 PMC: 4807991. DOI: 10.18632/oncotarget.6128.


References
1.
Keyse S . Dual-specificity MAP kinase phosphatases (MKPs) and cancer. Cancer Metastasis Rev. 2008; 27(2):253-61. DOI: 10.1007/s10555-008-9123-1. View

2.
Deveault C, Qian J, Chebaro W, Ao A, Gilbert L, Mehio A . NLRP7 mutations in women with diploid androgenetic and triploid moles: a proposed mechanism for mole formation. Hum Mol Genet. 2008; 18(5):888-97. DOI: 10.1093/hmg/ddn418. View

3.
Lin S, Coan P, da Rocha S, Seitz H, Cavaille J, Teng P . Differential regulation of imprinting in the murine embryo and placenta by the Dlk1-Dio3 imprinting control region. Development. 2006; 134(2):417-26. DOI: 10.1242/dev.02726. View

4.
Liu L, Channavajhala P, Rao V, Moutsatsos I, Wu L, Zhang Y . Proteomic characterization of the dynamic KSR-2 interactome, a signaling scaffold complex in MAPK pathway. Biochim Biophys Acta. 2009; 1794(10):1485-95. DOI: 10.1016/j.bbapap.2009.06.016. View

5.
Hertz R . Choriocarcinoma of women maintained in serial passage in hamster and rat. Proc Soc Exp Biol Med. 1959; 102:77-81. DOI: 10.3181/00379727-102-25149. View